BackFidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Accounts Payable

Track Fidelity Select Biotechnology Portfolio's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer trimmed avg / median

Loading

Fidelity Select Biotechnology Portfolio Accounts Payable History

Loading

Fidelity Select Biotechnology Portfolio vs. peers: Accounts Payable Comparison

Loading

Fidelity Select Biotechnology Portfolio Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

Fidelity Select Biotechnology Portfolio posts a accounts payable of $0 as of October 2023. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Accounts Payable is one piece of Fidelity Select Biotechnology Portfolio's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for FBIOX's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Fidelity Select Biotechnology Portfolio's other metric pages and overview cover the third.